Hemiplegia Clinical Trials

Find Hemiplegia Clinical Trials Near You

Robot-assisted Versus Conventional Physical Therapy for Hand in Sub-acute Stroke

Status: Recruiting
Location: See location...
Intervention Type: Device, Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This randomized controlled trial aims to compare the effectiveness of robotic-assisted physiotherapy and conventional physiotherapy in improving hand function among patients with sub-acute stroke. Stroke often results in weakness, reduced hand strength, impaired dexterity, and difficulty performing daily activities due to upper-limb motor dysfunction. Early rehabilitation targeting hand recovery is essential to improve independence and quality of life. A total of 30 participants with sub-acute post-stroke spastic hemiplegia will be recruited from the University of Lahore Hospital and randomly assigned into two groups. The intervention group will receive robotic-assisted physiotherapy focused on repetitive, task-specific wrist and finger extension training using a robotic hand/wrist device, while the control group will receive conventional therapist-led upper-limb rehabilitation exercises. Both groups will undergo treatment sessions lasting 30-45 minutes, five days per week for four weeks. Outcome measures will include hand muscle strength assessed using a hand-held dynamometer, hand dexterity evaluated through the Action Research Arm Test (ARAT), and functional improvement measured using the Fugl-Meyer Assessment for Upper Extremity (FMA-UE). Additional measures such as spasticity, activities of daily living, and quality of life will also be recorded. Assessments will be conducted at baseline, during treatment, and after completion of the intervention period by a blinded assessor. The study is expected to determine whether robotic-assisted physiotherapy provides greater improvements in hand strength, dexterity, and upper-limb functional recovery compared to conventional physiotherapy in individuals recovering from stroke. Findings from this research may contribute to evidence-based rehabilitation strategies for improving upper-limb outcomes after stroke.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 30
Maximum Age: 50
Healthy Volunteers: f
View:

• Both male and female adults aged 30-50 years diagnosed with post-stroke spastic hemiplegia confirmed by a neurologist.

• Stroke duration 2 weeks to 6 months (sub acute stage) with medically stable condition.

• Presence of mild to moderate upper-limb spasticity using screening test(Modified Ashworth Scale score 1-3).

• Ability to comprehend and follow simple verbal instructions using screening test (MMSE ≥ 24).

Locations
Other Locations
Pakistan
University of Lahore Teaching Hospital, Lahore
RECRUITING
Lahore
Contact Information
Primary
Muhammad Uzair, MSPTN
druzairmuhammad@gmail.com
03001850678
Backup
Montiha Azeem, MSPTN
muntahaazeem9@gmail.com
03479717317
Time Frame
Start Date: 2026-05-22
Estimated Completion Date: 2026-06-23
Participants
Target number of participants: 30
Treatments
Experimental: group A Robotic-Assisted Physiotherapy Group
Participants in this group will receive robotic-assisted physiotherapy focused on wrist and finger extension training using a robotic hand/wrist rehabilitation device. Treatment will include repetitive task-specific movements, active-assist and active-resist exercises, visual feedback tasks, and functional grasp-release training. Sessions will be conducted for 30-45 minutes per session, 5 days per week for 4 weeks under therapist supervision.
Active_comparator: group B Conventional Physiotherapy Group
Participants in this group will receive conventional therapist-led upper-limb rehabilitation consisting of active-assisted and active range-of-motion exercises, strengthening exercises for wrist and finger extensors, task-oriented functional training, neuromuscular facilitation, mirror therapy, and activities of daily living training. Sessions will be conducted for 30-45 minutes per session, 5 days per week for 4 weeks.
Sponsors
Leads: Montiha Azeem

This content was sourced from clinicaltrials.gov